{"id":"https://openalex.org/W3021180065","doi":"https://doi.org/10.21873/anticanres.14254","title":"Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient","display_name":"Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient","publication_year":2020,"publication_date":"2020-05-01","ids":{"openalex":"https://openalex.org/W3021180065","doi":"https://doi.org/10.21873/anticanres.14254","mag":"3021180065","pmid":"https://pubmed.ncbi.nlm.nih.gov/32366428"},"language":"en","primary_location":{"id":"doi:10.21873/anticanres.14254","doi":"https://doi.org/10.21873/anticanres.14254","is_oa":true,"landing_page_url":"https://doi.org/10.21873/anticanres.14254","pdf_url":"https://ar.iiarjournals.org/content/anticanres/40/5/2813.full.pdf","source":{"id":"https://openalex.org/S157347057","display_name":"Anticancer Research","issn_l":"0250-7005","issn":["0250-7005","1791-7530"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4320800545","host_organization_name":"International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts","host_organization_lineage":["https://openalex.org/P4320800545"],"host_organization_lineage_names":["International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ar.iiarjournals.org/content/anticanres/40/5/2813.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109489759","display_name":"Qinghong Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"QINGHONG HAN","raw_affiliation_strings":["AntiCancer, Inc., San Diego, CA, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AntiCancer, Inc., San Diego, CA, U.S.A","institution_ids":["https://openalex.org/I4210121314"]}]},{"author_position":"middle","author":{"id":null,"display_name":"YUYING TAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"YUYING TAN","raw_affiliation_strings":["AntiCancer, Inc., San Diego, CA, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AntiCancer, Inc., San Diego, CA, U.S.A","institution_ids":["https://openalex.org/I4210121314"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040819666","display_name":"Robert M. Hoffman","orcid":"https://orcid.org/0000-0002-0049-0041","observed_orcids":["https://orcid.org/0000-0002-0049-0041"]},"institutions":[{"id":"https://openalex.org/I4210121314","display_name":"AntiCancer (United States)","ror":"https://ror.org/02pp1v282","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121314"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ROBERT M. HOFFMAN","raw_affiliation_strings":["AntiCancer, Inc., San Diego, CA, U.S.A. all@anticancer.com","AntiCancer, Inc., San Diego, CA, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AntiCancer, Inc., San Diego, CA, U.S.A. all@anticancer.com","institution_ids":["https://openalex.org/I4210121314"]},{"raw_affiliation_string":"AntiCancer, Inc., San Diego, CA, U.S.A","institution_ids":["https://openalex.org/I4210121314"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210121314"],"apc_list":null,"apc_paid":null,"fwci":5.2988,"has_fulltext":true,"cited_by_count":85,"citation_normalized_percentile":{"value":0.97880478,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"40","issue":"5","first_page":"2813","last_page":"2819"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-methioninase","display_name":"recombinant methioninase","score":0.9819999933242798},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7070000171661377},{"id":"https://openalex.org/keywords/methionine-restriction","display_name":"methionine restriction","score":0.9269999861717224},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.8560000061988831},{"id":"https://openalex.org/keywords/bone-metastatic-prostate-cancer","display_name":"bone metastatic prostate cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hemoglobin-increase","display_name":"hemoglobin increase","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7380011677742004},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.708569347858429},{"id":"https://openalex.org/C2780912031","wikidata":"https://www.wikidata.org/wiki/Q180341","display_name":"Methionine","level":3,"score":0.6935848593711853},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5805822014808655},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5215389728546143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4392462372779846},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43419793248176575},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3660099506378174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10627561807632446},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07309257984161377},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013437","descriptor_name":"Carbon-Sulfur Lyases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013437","descriptor_name":"Carbon-Sulfur Lyases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.21873/anticanres.14254","doi":"https://doi.org/10.21873/anticanres.14254","is_oa":true,"landing_page_url":"https://doi.org/10.21873/anticanres.14254","pdf_url":"https://ar.iiarjournals.org/content/anticanres/40/5/2813.full.pdf","source":{"id":"https://openalex.org/S157347057","display_name":"Anticancer Research","issn_l":"0250-7005","issn":["0250-7005","1791-7530"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4320800545","host_organization_name":"International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts","host_organization_lineage":["https://openalex.org/P4320800545"],"host_organization_lineage_names":["International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Research","raw_type":"journal-article"},{"id":"pmid:32366428","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32366428","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.21873/anticanres.14254","doi":"https://doi.org/10.21873/anticanres.14254","is_oa":true,"landing_page_url":"https://doi.org/10.21873/anticanres.14254","pdf_url":"https://ar.iiarjournals.org/content/anticanres/40/5/2813.full.pdf","source":{"id":"https://openalex.org/S157347057","display_name":"Anticancer Research","issn_l":"0250-7005","issn":["0250-7005","1791-7530"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4320800545","host_organization_name":"International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts","host_organization_lineage":["https://openalex.org/P4320800545"],"host_organization_lineage_names":["International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3021180065.pdf","grobid_xml":"https://content.openalex.org/works/W3021180065.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W279302623","https://openalex.org/W1844255926","https://openalex.org/W1940550010","https://openalex.org/W1963404410","https://openalex.org/W1965110439","https://openalex.org/W1968282348","https://openalex.org/W1969600415","https://openalex.org/W1999839653","https://openalex.org/W2012110463","https://openalex.org/W2015556936","https://openalex.org/W2015898183","https://openalex.org/W2026863696","https://openalex.org/W2033026103","https://openalex.org/W2072823493","https://openalex.org/W2104349860","https://openalex.org/W2107117572","https://openalex.org/W2122134113","https://openalex.org/W2132970134","https://openalex.org/W2139283055","https://openalex.org/W2147892369","https://openalex.org/W2159118239","https://openalex.org/W2172255822","https://openalex.org/W2214621962","https://openalex.org/W2342714720","https://openalex.org/W2347178913","https://openalex.org/W2396466397","https://openalex.org/W2412208141","https://openalex.org/W2417563017","https://openalex.org/W2444538184","https://openalex.org/W2593558254","https://openalex.org/W2602989667","https://openalex.org/W2605117891","https://openalex.org/W2742450412","https://openalex.org/W2761141660","https://openalex.org/W2769053959","https://openalex.org/W2771508138","https://openalex.org/W2772407589","https://openalex.org/W2782140108","https://openalex.org/W2787956080","https://openalex.org/W2791425142","https://openalex.org/W2791517399","https://openalex.org/W2791533954","https://openalex.org/W2795762460","https://openalex.org/W2796729556","https://openalex.org/W2809668133","https://openalex.org/W2889504957","https://openalex.org/W2895370127","https://openalex.org/W2899301998","https://openalex.org/W2911898938","https://openalex.org/W2912789083","https://openalex.org/W2914401127","https://openalex.org/W2942752966","https://openalex.org/W2943637393","https://openalex.org/W2964871068","https://openalex.org/W2968237362","https://openalex.org/W2972800793","https://openalex.org/W2973184360","https://openalex.org/W2974260152","https://openalex.org/W2986720704","https://openalex.org/W2995884328","https://openalex.org/W2999417355"],"related_works":["https://openalex.org/W3148860823","https://openalex.org/W3175887392","https://openalex.org/W1975068462","https://openalex.org/W4394749536","https://openalex.org/W2913792595","https://openalex.org/W4210347876","https://openalex.org/W279302623","https://openalex.org/W2912655939","https://openalex.org/W4416821753","https://openalex.org/W4307842283"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Methionine":[1,11],"addiction":[2,12,25],"is":[3,142],"a":[4,43,56,66,80,90,162],"general":[5],"and":[6,28,141,167],"fundamental":[7],"hallmark":[8],"of":[9,112,116,150,171],"cancer.":[10],"can":[13,164],"be":[14],"targeted":[15],"by":[16],"methionine":[17,24,105],"restriction":[18],"(MR).":[19],"Our":[20],"laboratory":[21],"has":[22,137],"studied":[23],"in":[26,48],"cancer":[27,49,62,154],"MR":[29,47],"for":[30,73],"almost":[31],"50":[32],"years.":[33],"The":[34,101,118],"present":[35],"study":[36],"describes":[37],"oral":[38],"recombinant":[39],"methioninase":[40],"(o-rMETase),":[41],"as":[42,161],"supplement,":[44,163],"to":[45,157],"induce":[46],"patients.":[50],"PATIENTS":[51],"AND":[52],"METHODS:":[53],"One":[54],"patient,":[55,79],"67-year-old":[57],"female":[58],"with":[59,83,152],"high-stage":[60,153],"ovarian":[61],"took":[63,87],"o-rMETase":[64,88,136],"twice":[65,89],"day":[67,91],"at":[68,92],"250":[69,93,114],"units":[70,94,115],"per":[71,95],"dose":[72,96],"approximately":[74,123],"one":[75],"month.":[76],"A":[77],"second":[78,119],"76-year-old":[81],"male":[82],"bone-metastatic":[84],"prostate":[85],"cancer,":[86],"during":[97],"three":[98],"months.":[99,127],"RESULTS:":[100],"first":[102],"patient's":[103,120,132],"circulating":[104],"levels":[106],"decreased":[107],"50%":[108],"within":[109],"4":[110],"hours":[111],"taking":[113],"o-rMETase.":[117],"PSA":[121],"dropped":[122],"70%":[124],"over":[125],"3":[126],"During":[128],"this":[129],"time":[130],"the":[131,169],"hemoglobin":[133],"increased.":[134],"CONCLUSION:":[135],"no":[138],"side":[139],"effects":[140],"potentially":[143],"efficacious.":[144],"Future":[145],"studies":[146],"involving":[147],"larger":[148],"cohorts":[149],"patients":[151],"are":[155],"required":[156],"determine":[158],"if":[159],"o-rMETase,":[160],"increase":[165],"survival":[166],"improve":[168],"quality":[170],"life.":[172]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":23},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-05-13T00:00:00"}